Serious Game to Promote Transition Readiness Skills for Patients With Congenital Heart Disease
Launched by UNIVERSITY OF UTAH · Jun 19, 2025
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new video game designed to help teenagers with congenital heart disease—a condition they are born with that affects their heart—learn how to take care of their health as they grow older. The game teaches important skills like how to talk with doctors, understand medical information, and keep track of appointments and medications. The study will see if the game is easy to use, if teens and their families like it, and if it helps young people feel more confident and ready to manage their heart health on their own.
Teens with congenital heart disease, along with their parents and healthcare providers, are invited to take part in this study. Participants should be able to see and play the game without difficulty. During the study, they will play the game and share feedback about their experience. The researchers will also look at how the game affects communication between teens and their doctors during visits. This pilot study aims to find out if this video game could be a useful tool to support young people as they prepare to transition from pediatric to adult heart care.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • - Patient with congenital heart disease, their parent, and their clinician
- Exclusion criteria:
- • -Significant visual or cognitive impairment that would impede their ability to play the game and/or complete the study.
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported